Multiple Slerrosis Papers

Multiple sclerosis, also known as MS, is one of the humankind’s most mysterious diseases. Multiple sclerosis has the ability to affect nearly 3 million people worldwide. This disease tends to be more common in individuals of northern European descent and women are more than twice as likely to develop multiple sclerosis as men are. Of those 3 million people, most of them are between the ages of 20 and 50 years old. Even though multiple sclerosis is a mystery disease, scientists are working to determine the exact cause and treatment.

Multiple sclerosis is an autoimmune disease that involves the different areas of the central nervous system, the brain, and spinal cord. It damages the myelin sheath, the material that surrounds and protects the

It is also estimated that approximately two and half million people are living with the disease... The name multiple sclerosis refers to the scars that are present in the brain and spinal cord is seen on an MRI. An autoimmune disorder is where a person’s immune system mistakes its own white blood cells as invaders and begins to attack itself damaging healthy body tissue. In these types of disorders, the immune system cannot tell the difference between healthy cells and antigens, which are foreign invaders like bacteria and viruses. Because of the damage, it does to the nerve cells; nerve signals can either slow down or stop completely. Inflammation, or the body’s reaction to infection, is what causes this nerve damage to happen. Multiple sclerosis is most commonly seen in the brain, optic nerve, and spinal cord and often leads to physical and cognitive

Physical and occupational therapy may also help. Multiple sclerosis is not a fatal disease. Most people with MS have a normal or near-normal life span and usually die from the same conditions that affect general population (heart disease, cancer). Multiple Sclerosis symptoms can negatively affect the quality of life. Suicide rates among patients with multiple sclerosis are higher than average. The majority of patients with MS do not become severely disabled. Women tend to have a better outlook than men. MS has long been known, yet diagnosis remains difficult due to the complexity of the disease and its wide array of signs and symptoms. Treating MS still relies on symptomatic relief, but therapeutic advances in the form of DMDs have shown promising